KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03779282

Enrollment

Registered

2018-12-19

Start date

2018-02-15

Completion date

2018-09-15

Last updated

2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Delirium, Strabismus

Brief summary

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

Interventions

DRUGDexmedetomidine

see descriptions

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Yes

Inclusion criteria

* ASA I/II children undergoing outpatient strabismus surgery

Exclusion criteria

* anything not meeting the above

Design outcomes

Primary

Measure	Time frame	Description
Pediatric Anesthesia Emergence Delirium scale scores	up to 6 hours in recovery room	A low total score would indicate less emergence delirium

Secondary

Measure	Time frame	Description
wong-baker or numeric pain scores, depending on age	up to 6 hours in recovery room	A low total score would indicate less pain
discharge time	up to 24 hours	time the patient is actually discharged from recovery room

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026